浏览全部资源
扫码关注微信
成都中医药大学 民族医药学院,民族医药学术传承创新研究中心,成都 611137
刘紫轩,在读硕士,从事中西医、民族医学特色诊疗技术及信息化研究,E-mail:2094125118@qq.com
俞佳,在读博士,讲师,从事民族医药资源及信息化研究,E-mail:13515094@qq.com
纸质出版日期:2021-01-20,
网络出版日期:2020-11-17,
收稿日期:2020-08-02,
扫 描 看 全 文
刘紫轩,文成当智,张艺等.基于文本关联的藏族药药名规范化及其与法定药品标准的关系[J].中国实验方剂学杂志,2021,27(02):172-180.
LIU Zi-xuan,WENCHENG Dang-zhi,ZHANG Yi,et al.Research on Standardization of Tibetan Medicine Names and Their Relationship With Official Drug Standards Based on Text Association[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(02):172-180.
刘紫轩,文成当智,张艺等.基于文本关联的藏族药药名规范化及其与法定药品标准的关系[J].中国实验方剂学杂志,2021,27(02):172-180. DOI: 10.13422/j.cnki.syfjx.20210115.
LIU Zi-xuan,WENCHENG Dang-zhi,ZHANG Yi,et al.Research on Standardization of Tibetan Medicine Names and Their Relationship With Official Drug Standards Based on Text Association[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(02):172-180. DOI: 10.13422/j.cnki.syfjx.20210115.
目的
2
构建藏族药(简称藏药)成方制剂知识库,探索藏药成方制剂组方药名规范化。
方法
2
采用“人机结合”理念,通过构建藏药名词术语词表(数据来源为国家药品标准、地方药品标准、藏族医药经典著作等),对藏药成方制剂的组方数据进行词表挖掘,结合专家审核,构建藏药成方制剂组方药与各药品标准、辞典间的文本关联,探索组方药名的规范化方法及技术。
结果
2
该文以我国批准上市的藏药成方制剂作为研究对象,揭示了组方药名与药材名不统一带来的种种不便,并从文本关联、评价方法优化、专家决策体系形成,3个层次探讨藏成药组方药名规范化的设计思路,提出“筛评校定新”五位一体藏药药名规范化研究模式。详述了藏药成方制剂数据库及专业词表的构建、功能和优势,结合文本注释,建立了标准的药材部分和成方制剂部分的关联。
结论
2
文本关联法较为准确反映了藏药成方制剂组方药名的不规范现象,结合专家审核,在一定程度上可以推广到规模较大或网络结构更复杂的组方药名规范化中。
Objective
2
To construct the knowledge base of Tibetan medicine prescriptions and explore to standardize the names of Tibetan medicine prescriptions.
Method
2
By using the concept of "man-machine combination",through the construction of Tibetan medicine terminology glossary (data sources: national drug standards,local drug standards,text classics on Tibetan medicines,etc.),the terminology glossary of Tibetan medicine prescriptions was mined. Upon its combination with expert review,the text association between Tibetan medicine prescriptions and various drug standards and dictionaries was constructed,and the standardization methods and techniques of prescription drug names were explored.
Result
2
In this paper,the Tibetan medicine prescriptions approved for marketing in China were taken as the research object,and various inconveniences caused by the inconsistency between the names of prescriptions and the names of medicinal herbs were revealed. This paper also discussed the design ideas on name standardization of Tibetan medicines from three levels: text association,optimization of evaluation methods,and formation of expert decision-making system. We put forward a five-in-one (screening, evaluation, reviewing, fixing, and renewing) research model of Tibetan medicine name standardization. The construction,functions and advantages of the database and thesaurus of Tibetan medicine prescriptions were described in detail, and in combination with the text notes, association between the standard medicinal materials and the prepared prescriptions was then established.
Conclusion
2
The text association method in this paper can accurately reflect the nonstandard names of Tibetan medicine prescriptions. Combined with expert review,it can be, to a certain extent, extended to the standardization of herb names in prescriptions with large scale of or more complex network structures.
藏族药知识库名词术语规范化文本挖掘
Tibetan medicineknowledge baseterminologynormalizationtext mining
SCHWABL H,VENNOS C.From medical tradition to traditional medicine: A Tibetan formula in the European framework[J].J Ethnopharmacol,2015,167:108-114.
王正山,朱建平.中医药术语同义词查询数据库建设初探[J].中国科技术语,2019,21(1):48-51.
贾敏如,张艺.中国民族药辞典[M].北京:中国医药科技出版社,2016.
GUO Q,BAI R,ZHAO B,et al.An ethnopharmacological,phytochemical and pharmacological review of the genus Meconopsis[J].Am J Chin Med,2016,44(3):439-462.
MA L,GU R,TANG L,et al.Important poisonous plants in tibetan ethnomedicine[J].Toxins (Basel),2015,7(1):138-155.
BHATTACHARYA A,DHIMAN N.Nardostachys jatamansi (D.Don) DC.-challenges and opportunities of harnessing the untapped medicinal plant from the Himalayas[J].J Ethnopharmacol,2020,246:112211.
ZHENG H,LIU T,LIE T,et al.Promising potentials of Tibetan macaques in xenotransplantation[J].Xenotransplantation,2019,26(1):e12489.
朱建平.中成药通用名称命名之商榷[J].中国科技术语,2017,19(3):26-31.
朱建平.中医药名词术语规范化现状问题与对策[J].中华中医药杂志,2017,32(4):1633-1637.
赵芡,刘辉婧,李秋月,等.藏药名称规范问题探讨[J].中药与临床,2017,8(4):42-45.
毛萌,任小巧,杨秀岩,等.藏药质量标准现状及其研究对策[J].中医杂志,2015,56(8):640-644.
王景霞,任小巧.民族医药标准化建设现状及思考[J].中华中医药杂志,2013,28(11):3145-3148.
曹雨虹,谭睿,谢彬,等.藏药资源概况及品种整理[J].世界科学技术—中医药现代化,2012,14(1):1184-1188.
中国国家标准(GB)题录(上)[J].世界标准信息,2003(1):14-97.
ISO 18662-1:2017中医药-术语-第一部分中药材术语国际标准正式出版发布[J].世界中医药,2017,12(8):1953.
宋宗华,王海南,王立新,等.从中药配方颗粒标准研究探讨国家药品标准形成机制[J].中国实验方剂学杂志,2020,26(13):206-211.
赵宇新,麻广霖.建立国家药品标准复审制度的思考与建议[J].中国实验方剂学杂志,2020,26(16):205-209.
范铁兵,宁秋萍,杨志旭,等.基于数据挖掘技术的中医学隐性知识显性化分析[J].中国实验方剂学杂志,2017,23(10):221-226.
宋民宪.民族药成方制剂[M].北京:人民卫生出版社,2014:4.
国家药典委员会.中华人民共和国药典:一部[M].北京:中国医药科技出版社,2020.
中华人民共和国卫生部药典委员会.中华人民共和国卫生部药品标准:藏药分册[M].北京:人民卫生出版社,1995.
国家中医药管理局《中华本草》编委会.中华本草:藏药卷[M].上海:上海科学技术出版社,2002.
杜欢,徐僮,李海娇,等.粪便类藏药的文献考证及研究现状[J].中国中药杂志,2018,43(5):1054-1061.
高新颜,朱建平,刘力力,等.论中医药名词定名单义性原则的实施[J].中国科技术语,2013,15(3):17-20.
XU H,ZHANG Y,LIU Z,et al.ETCM:an encyclopaedia of traditional Chinese medicine[J].Nucleic Acids Res,2019,47(D1):D976-D982.
张功,于莹,黄海量,等.基于网络药理学和生物信息学探讨四神丸治疗溃疡性结肠炎的作用机制[J].中国实验方剂学杂志,2019,25(24):142-149.
蔺亚东,高文静,侯敏,等.基于网络药理学探讨芪术颗粒治疗糖尿病肾病的作用机制[J].中国实验方剂学杂志,2020,26(24):161-168.
杨婷,陈利娜,瞿水清,等.基于网络药理学探讨芪术颗粒治疗糖尿病肾病的作用机制[J].中国实验方剂学杂志,2020,26(17):151-161.
于嘉祥,王安娜,郑一,等.基于网络药理学的半夏-橘红药对治疗代谢综合征的作用机制探析[J].中国实验方剂学杂志,2020,26(21):118-128.
苏晓乾,夏长波,严福林,等.基于网络药理学和分子对接研究淫羊藿治疗抑郁症的抗炎作用机制[J].中国实验方剂学杂志,2020,26(17):162-169.
WU Y,ZHANG F,YANG K,et al.SymMap: an integrative database of traditional Chinese medicine enhanced by symptom mapping[J].Nucleic Acids Res,2019,47(D1):D1110-D1117.
KRALLINGER M,RABAL O,LOURENCO A,et al.Information retrieval and text mining technologies for chemistry[J].Chem Rev,2017,117(12):7673-7761.
李凤超,李惠敏,刚焕晨雷,等.灰毛党参资源及药用情况调查[J].中国实验方剂学杂志,2021,27(1):172-180.
任玲玲,毛竹,曾金祥,等.基于靶细胞捕集与分子对接的藏族药短管兔耳草调控URAT1活性成分筛选[J].中国实验方剂学杂志,2020,26(17):119-125.
0
浏览量
10
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构